Waystar's Modest FY25 Outlook Faces Growth Challenges: Goldman Sachs Analyst Weighs In Goldman Sachs analyst reiterates Buy rating on Waystar with $52 price forecast. Despite 2024 outperformance, stock has fallen 14% since Q4.
Waystar (WAY) Reports Q4: Everything You Need To Know Ahead Of Earnings Healthcare technology company Waystar Holding (
NASDAQ:WAY )
will be reporting results tomorrow morning. Here’s what to look for.
Short Waystar Holding Corp. Ahead Of Lockup Expiration As the lockup period for Waystar Holding Corp. (Nasdaq: WAY) ends on December 4, pre-IPO shareholders and insiders can sell their shares, which are currently under restriction.
IPOs 2024: Waystar Delivers A Successful IPO Earlier this year, healthcare payments technology provider, Waystar went public to a tepid debut. The market seems to have improved now and the stock has been climbing since.
WAY Stock Earnings: Waystar Holding Beats EPS, Beats Revenue for Q2 2024 WAY stock results show that Waystar Holding beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
IPO Watch: 3 New Stocks Worth a Strong Look Explore promising new IPOs in 2024, featuring standout companies like Tempus AI, Waystar, and Webtoon amid a revitalized market.
Analysts Rally Behind Waystar: Predict Robust Growth and Market Share Gains Following Competitor Setback Waystar Holding Corp. garners bullish analyst coverage on growth prospects fueled by market demand, competitive advantages, and post-cyberattack opportunities.
